Brief: Arecor Therapeutics Updates on Progress Of Phase I Clinical Study Of At278
Oct 2 (Reuters) - Arecor Therapeutics PLC AREC.L :
* ARECOR THERAPEUTICS - PROGRESS OF PHASE I CLINICAL STUDY
OF
AT278
Source text for Eikon: ID:nRSB2656Oa
Further company coverage: AREC.L
((Reuters.Briefs@thomsonreuters.com;))